Anixa Biosciences Inc 10-Q filing
Filed 2026-06-10 · Report date 2026-04-30 · 2026
Filing metadata
- Accession number
- 0001493152-26-028105
- Form type
- 10-Q
- CIK
- 0000715446
- Primary document
- https://www.sec.gov/Archives/edgar/data/715446/000149315226028105/form10-q.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Anixa Biosciences Inc.
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Operating Income | $-5.4M | - | - |
| Net Income | $-5.1M | - | - |
| Eps Basic | -0.15 | - | - |
| Eps Diluted | -0.15 | - | - |
| Cash And Equivalents | $1.5M | - | - |
| Total Assets | $14.9M | - | - |
| Total Liabilities | $1.6M | - | - |
| Shareholders Equity | $14.5M | - | - |
| Operating Cash Flow | $-4.4M | - | - |